In brain tissues of AD patients, the level of CD3+ T cells in peripheral blood vessels is related to Tau protein, rather than Aβ [101], suggesting that Tau-related neurodegenerative changes drive the intervention of peripheral immune substances. The gene discussed is MAPT; the disease is Alzheimer disease.